KLCM Advisors Inc. Purchases 82 Shares of McKesson Co. (NYSE:MCK)

KLCM Advisors Inc. increased its position in shares of McKesson Co. (NYSE:MCK) by 15.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 630 shares of the company’s stock after acquiring an additional 82 shares during the period. KLCM Advisors Inc.’s holdings in McKesson were worth $292,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of MCK. Covestor Ltd increased its stake in shares of McKesson by 72.3% in the first quarter. Covestor Ltd now owns 81 shares of the company’s stock valued at $25,000 after buying an additional 34 shares during the period. OFI Invest Asset Management acquired a new stake in shares of McKesson in the third quarter valued at about $26,000. Legacy Financial Group LLC acquired a new stake in shares of McKesson in the third quarter valued at about $27,000. Live Oak Investment Partners acquired a new stake in shares of McKesson in the fourth quarter valued at about $30,000. Finally, BKM Wealth Management LLC acquired a new stake in shares of McKesson in the fourth quarter valued at about $31,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on MCK shares. Mizuho raised their target price on McKesson from $450.00 to $505.00 and gave the stock a “neutral” rating in a research note on Friday, February 9th. Morgan Stanley raised their target price on McKesson from $522.00 to $548.00 and gave the stock an “overweight” rating in a research note on Monday. Leerink Partnrs reaffirmed an “outperform” rating on shares of McKesson in a research note on Monday, February 26th. Barclays started coverage on McKesson in a research note on Wednesday, January 3rd. They set an “overweight” rating and a $537.00 target price for the company. Finally, Argus raised their target price on McKesson from $510.00 to $570.00 and gave the stock a “buy” rating in a research note on Wednesday, April 10th. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $533.50.

Insider Activity

In other news, CEO Brian S. Tyler sold 3,473 shares of the firm’s stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $524.55, for a total value of $1,821,762.15. Following the transaction, the chief executive officer now owns 43,445 shares in the company, valued at $22,789,074.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Brian S. Tyler sold 3,473 shares of McKesson stock in a transaction on Friday, March 15th. The stock was sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the sale, the chief executive officer now directly owns 43,445 shares in the company, valued at $22,789,074.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Leann B. Smith sold 186 shares of McKesson stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total value of $92,256.00. Following the sale, the executive vice president now owns 1,511 shares in the company, valued at $749,456. The disclosure for this sale can be found here. Corporate insiders own 0.21% of the company’s stock.

McKesson Stock Down 0.5 %

MCK stock opened at $525.92 on Thursday. McKesson Co. has a twelve month low of $352.34 and a twelve month high of $543.00. The stock’s 50 day moving average is $523.95 and its 200-day moving average is $485.48. The firm has a market capitalization of $69.11 billion, a PE ratio of 23.83, a P/E/G ratio of 1.43 and a beta of 0.45.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, February 7th. The company reported $7.74 earnings per share for the quarter, beating analysts’ consensus estimates of $7.05 by $0.69. McKesson had a negative return on equity of 262.63% and a net margin of 0.99%. The company had revenue of $80.90 billion for the quarter, compared to analyst estimates of $77.93 billion. During the same quarter last year, the company earned $6.90 earnings per share. The company’s revenue for the quarter was up 14.8% on a year-over-year basis. On average, equities research analysts anticipate that McKesson Co. will post 27.59 earnings per share for the current fiscal year.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Friday, March 1st were issued a $0.62 dividend. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $2.48 dividend on an annualized basis and a dividend yield of 0.47%. McKesson’s dividend payout ratio is presently 11.24%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.